Fibrates improve liver tests in primary sclerosing cholangitis with incomplete biochemical response to ursodeoxycholic acid: update of a pilote study

被引：0
|
作者：
Lemoinne, Sara [1 ,2 ,3 ]
Corpechot, Christophe [1 ,2 ,3 ]
Fankem, Astrid Donald D. Kemgang [1 ,2 ,3 ]
Gaouar, Farid [1 ]
Poupon, Raoul [1 ,2 ,3 ]
Chazouilleres, Olivier [1 ,2 ,3 ]
机构：
[1] Hop St Antoine, AP HP, Serv Hepatol, Ctr Reference Malad Inflammatoires Voies Biliaire, F-75571 Paris, France
[2] INSERM, UMRS 938, F-75012 Paris, France
[3] Univ Paris 06, F-75012 Paris, France
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
335
引用
收藏
页码：368A / 368A
页数：1
相关论文
共 50 条
  • [41] Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
    Levy, C.
    Peter, J. A.
    Nelson, D. R.
    Keach, J.
    Petz, J.
    Cabrera, R.
    Clark, V.
    Firpi, R. J.
    Morelli, G.
    Soldevila-Pico, C.
    Lindor, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 235 - 242
  • [42] Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis
    Cancado, Guilherme Grossi Lopes
    Fucuta, Patricia da Silva
    Gomes, Nathalia Mota de Faria
    Couto, Claudia Alves
    Cancado, Eduardo Luiz Rachid
    Terrabuio, Debora Raquel Benedita
    Villela-Nogueira, Cristiane Alves
    Braga, Michelle Harriz
    Nardelli, Mateus Jorge
    Faria, Luciana Costa
    Oliveira, Elze Maria Gomes
    Rotman, Vivian
    Oliveira, Maria Beatriz
    da Cunha, Simone Muniz Carvalho Fernandes
    Silva, Marlone Cunha da
    Mendes, Liliana Sampaio Costa
    Ivantes, Claudia Alexandra Pontes
    Codes, Liana
    de Almeida e Borge, Valeria Ferreira
    Pace, Fabio Heleno de Lima
    Pessoa, Mario Guimaraes
    Signorelli, Izabelle Venturini
    Coral, Gabriela Perdomo
    Bittencourt, Paulo Lisboa
    Ferraz, Maria Lucia Gomes
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)
  • [43] High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
    Olsson, R
    Boberg, KM
    De Muckadell, OS
    Lindgren, S
    Hultcrantz, R
    Folvik, G
    Bell, H
    Gangsoy-Kristiansen, M
    Matre, J
    Rydning, A
    Wikman, O
    Danielsson, Å
    Sandberg-Gertzén, H
    Ung, KA
    Eriksson, A
    Lööf, L
    Prytz, H
    Marschall, HL
    Broomé, U
    GASTROENTEROLOGY, 2005, 129 (05) : 1464 - 1472
  • [44] A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis
    Sterling, RK
    Salvatori, JJ
    Luketic, VA
    Sanyal, AJ
    Fulcher, AS
    Stravitz, RT
    Contos, MJ
    Mills, AS
    Shiffman, ML
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (09) : 943 - 949
  • [45] Week-4 Biochemical Response Predicts 1-Year-Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients
    Shi, Yiwen
    Duan, Weijia
    Wang, Yu
    Ou, Xiaojuan
    Ma, Hong
    Jia, Jidong
    HEPATOLOGY, 2017, 66 : 176A - 176A
  • [46] Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis
    Komatsu, K
    Shimosegawa, T
    Kikuchi, S
    Uchi, M
    Maruhama, Y
    Kisara, N
    Ueno, Y
    Toyota, T
    INTERNAL MEDICINE, 2000, 39 (12) : 1049 - 1053
  • [47] Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis
    Tang, Libo
    Zhong, Ruihua
    He, Xuanqiu
    Wang, Weibin
    Liu, Jinhong
    Zhu, Youfu
    Li, Yongyin
    Hou, Jinlin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 659 - 666
  • [48] Results of a randomised controlled trial of budesonide add-on therapy in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid
    Hirschfield, G.
    Kupcinskas, L.
    Ott, P.
    Beuers, U.
    Bergquist, A. M.
    Farkkila, M.
    Manns, M. P.
    Pares, A.
    Spengler, U.
    Greinwald, R.
    Proels, M.
    Poupon, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S38 - S38
  • [49] Improvement in Predicted Survival after 26 Weeks of Treatment with Seladelpar in Patients with Primary Biliary Cholangitis and an Incomplete Response to Ursodeoxycholic Acid
    Hansen, Bettina E.
    Gulamhusein, Aliya
    Amato, Gianni
    Boudes, Po
    Hirschfield, Gideon
    HEPATOLOGY, 2018, 68 : 1087A - 1088A
  • [50] Good performance of the biochemical response criteria after three months of ursodeoxycholic acid treatment in patients with primary biliary cholangitis
    Patricia Llovet, Laura
    Reig, Anna
    Ortiz, Oswaldo
    Carlota Londono, Maria
    Pares, Albert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E401 - E401
12345